Yogurt Gel: Healing Tissue Breakthrough by Columbia Scientists
Yogurt’s Tiny Messengers: A Sweet Surprise for Regenerative Medicine
new injectable hydrogel platform harnesses milk-derived extracellular vesicles to revolutionize tissue repair.
In a groundbreaking advancement for regenerative medicine, researchers have unveiled an innovative injectable hydrogel platform that utilizes extracellular vesicles (EVs) derived from milk, specifically from yogurt, to overcome significant barriers in biomaterial development. Published in the journal Matter, this research, led by Santiago correa, assistant professor of biomedical engineering at Columbia Engineering, promises to usher in a new era of accessible and effective therapeutic materials.
Extracellular vesicles, tiny particles naturally secreted by cells, are biological powerhouses, carrying hundreds of crucial signals like proteins and genetic material.this intricate cellular dialog is notoriously arduous to replicate with synthetic materials. However, Correa and his team have ingeniously designed a hydrogel system where these milk-derived evs play a dual role: they act as potent bioactive cargo and, remarkably, serve as essential structural building blocks. By crosslinking biocompatible polymers, these EVs create an injectable material that mimics the mechanics of living tissue and actively engages surrounding cells, thereby promoting healing and tissue regeneration without the need for additional chemical additives.
The unconventional approach of leveraging yogurt EVs proved instrumental in overcoming the yield constraints that have historically hampered the development of EV-based biomaterials. “This project started as a basic question about how to build EV-based hydrogels,” explained Correa. “Yogurt evs gave us a practical tool for that, but they turned out to be more than a model. We found that they have inherent regenerative potential, which opens the door to new, accessible therapeutic materials.”
Correa, who directs the Nanoscale Immunoengineering Lab at Columbia University and is a member of the Herbert Irving Complete Cancer Center, collaborated with fellow Columbia Engineering faculty member Kam leong. The study was further bolstered by an international partnership with researchers from the University of Padova, including Elisa Cimetta and graduate student Caterina Piunti. This synergy, combining Padova’s expertise in agricultural EV sourcing with the Correa lab’s proficiency in nanomaterials and polymer-based hydrogels, underscores the power of cross-disciplinary, global collaborations in driving biomaterial innovation.
The team’s success in using yogurt-derived EVs has allowed them to define a design space for generating hydrogels that integrate EVs as both structural and biological components. Further validation using evs from mammalian cells and bacteria demonstrated the platform’s modularity and compatibility with diverse vesicle sources. This opens up exciting possibilities for advanced applications in wound healing and regenerative medicine, areas where current treatments often struggle to achieve long-term tissue repair. By embedding EVs directly into the hydrogel structure, the material facilitates sustained delivery of their bioactive signals, and its injectable nature allows for precise local delivery to damaged tissues.Early experimental results in immunocompetent mice have been highly promising. yogurt EV hydrogels proved to be biocompatible and exhibited potent angiogenic activity within a week, demonstrating that agricultural EVs are not only valuable for fundamental biomaterials research but also hold significant therapeutic potential as a next-generation biotechnology. The material showed no adverse reactions and, instead, actively promoted the formation of new blood vessels – a critical factor in effective tissue regeneration. Correa’s team also observed that the hydrogel cultivates a unique immune environment rich in anti-inflammatory cell types, which may play a crucial role in the observed tissue repair processes. The researchers are now actively investigating how this immune response can be harnessed to guide tissue regeneration more effectively.
“Being able to design a material that closely mimics the body’s natural environment while also speeding up the healing process opens a new world of possibilities for regenerative medicine,” commented Artemis Margaronis, an NSF graduate research fellow in the Correa lab and a key contributor to the study. “Moments like these remind me why the research field in biomedical engineering is always on the cusp of something exciting.” This innovative approach, born from an unexpected source, is poised to transform how we heal and regenerate damaged tissues.